Two cases of TSC2/PKD1 contiguous gene deletion syndrome
Author(s) -
Jihye You,
Eungu Kang,
Yoon-Myung Kim,
Beom Hee Lee,
TaeSung Ko,
Gu-Hwan Kim,
JinHo Choi,
HanWook Yoo
Publication year - 2016
Publication title -
journal of genetic medicine
Language(s) - English
Resource type - Journals
eISSN - 2233-9108
pISSN - 1226-1769
DOI - 10.5734/jgm.2016.13.1.36
Subject(s) - tsc2 , pkd1 , tsc1 , multiplex ligation dependent probe amplification , tuberous sclerosis , autosomal dominant polycystic kidney disease , epilepsy , biology , genetics , pathology , medicine , cyst , gene , exon , neuroscience , apoptosis , pi3k/akt/mtor pathway
[2]. Sporadic cases constitute two thirds of tuberous sclerosis cases. TSC2 mutations are about four times more frequent in sporadic cases compared to TSC1 mutations and cause a more severe phenotype [3]. Autosomal dominant polycystic kidney disease (ADPKD, MIM#173900) is a common renal disorder, occurring in approximately 1 in every 1,000 live births [4]. It is characterized by progressive bilateral renal cysts leading to renal failure in the fifth to seventh decade of life. Occasionally, liver cysts and intracranial aneurysm may occur. Mutations in PKD1 on 16p13.3, encoding polycystin 1, or PKD2 on 4q22, encoding Two cases of TSC2/PKD1 contiguous gene deletion syndrome
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom